Neuren Pharmaceuticals reported AUD2.69B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Alaunos Therapeutics USD 3M 2M Dec/2024
Avita Medical AUD 335.59M 29.1M Dec/2024
Clinuvel Pharmaceuticals AUD 603.73M 166.36M Dec/2024
Dianthus Therapeutics USD 692M 93M Sep/2025
Genetic Signatures AUD 143.1M 20.03M Dec/2024
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Neuren Pharmaceuticals AUD 1.6B 1.12B Dec/2024
Organon & Co USD 2.41B 108.26M Sep/2025
Paradigm Biopharmaceuticals AUD 145.99M 56.79M Dec/2024
Tectonic Therapeutic USD 377M 6M Sep/2025
Viatris USD 10.48B 83.95M Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025